ADC vs PDC

Business news, market intelligence, and global industry analysis.

The Latest

Netmarble Corporation bets on staged rollout to de-risk The Seven Deadly Sins: Origin open-world expansion

The real reason Netmarble is launching The Seven Deadly Sins: Origin in phases

Longeveron Inc. appoints Stephen H. Willard as CEO ahead of pivotal Phase 2b stem cell data

Philadelphia jury orders Johnson & Johnson to pay $250,000 in talc powder lawsuit

Representative image showing the intersection of financial performance and cancer diagnostics, reflecting Exact Sciences’ record 2025 results and its pending acquisition by Abbott Laboratories.

Exact Sciences (NASDAQ: EXAS) earnings show why Abbott moved now on a $21bn diagnostics acquisition

Representative image comparing antibody-drug conjugates (ADCs) and peptide drug conjugates (PDCs), illustrating the tumor-targeted delivery mechanisms explored in Avacta’s pre|CISION oncology platform.

Can Avacta’s peptide drug conjugates rival ADCs? The next chapter in targeted cancer delivery

Avacta’s peptide drug conjugates could change how we deliver cancer drugs. Find out how they compare to ADCs and what’s next for the UK biotech’s platform.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

September 5, 2025